Oragenics Inc (OGEN)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $893,370
Last updated: Nov 17, 2026 at 4:27 PM ET
Oragenics Inc (OGEN) Statistics
Oragenics (OGEN) has a market cap of $893,370. Its share count is up 189.06% from a year earlier. It holds $1.83M more cash than debt, 204.93% of its market cap.
Total Valuation
| Market Cap | $893,370 |
|---|---|
| Latest price (Nov 17, 2026) | $0.21 |
Key Dates
The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 15, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 81.25% over 52 weeks and trades 51.16% below its 50-day average.
| Beta (1Y) | 1.27 |
|---|---|
| 52-Week Change | -81.25% |
| 1-Month Change | -50.24% |
| 3-Month Change | -60.39% |
| 6-Month Change | -63.39% |
| 5-Year Change | -99.97% |
| 10-Year Change | -100.00% |
| Total Return (1Y) | -81.25% |
| Total Return (3Y CAGR) | -87.52% |
| Total Return (5Y CAGR) | -81.71% |
| Max Drawdown (1Y) | -82.16% |
| Max Drawdown (3Y) | -99.90% |
| Sharpe Ratio (1Y) | -1.91 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $0.43 |
| 200-Day Average | $0.57 |
| 52-Week Range | $0.17 to $1.11 |
| RSI (14 Days) | 18.3 |
| Average Volume (20 Days) | 2.61M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.50x current liabilities, and total debt is 0.36x shareholder equity.
| Current Ratio | 1.50x |
|---|---|
| Quick Ratio | 1.50x |
| Debt / Equity | 0.36x |
| Interest Coverage | -550.98x |
Returns and Efficiency
Return on invested capital is -656.14% and return on equity is -880.59% over the last 12 months.
| Return on Equity (ROE) | -880.59% |
|---|---|
| Return on Assets (ROA) | -293.14% |
| Return on Invested Capital (ROIC) | -656.14% |
Scores
OGEN has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue of $0 over the last 12 months is down 100.00% from the 12 months before.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Operating Income | -$9.94M |
| Pretax Income | -$9.85M |
| Net Income | -$9.62M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 33.23% of the $3.28M in total assets.
| Cash and Equivalents | $2.23M |
|---|---|
| Total Debt | $396.59K |
| Net Cash | $1.83M |
| Net Cash Per Share | $0.41 |
| Working Capital | $1.09M |
| Shareholder Equity | $1.09M |
| Book Value Per Share | $0.24 |
| Total Assets | $3.28M |
| Total Liabilities | $2.19M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$9.26M |
|---|---|
| FCF Per Share | -$2.05 |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | +25.89% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +25.89% |
Dividends and Yields
OGEN does not pay a dividend.
| Buyback Yield | -8.24% |
|---|---|
| Shareholder Yield | -8.24% |
Stock Splits
The last split was a 1-for-30 reverse split on Jun 3, 2025.
| Last Split Date | Jun 3, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:30 |
Peer Position
Against 3 similar companies, OGEN has the lowest ROIC.
ROICPeer median -187.86%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -27.45%
| ROIC | -656.14% vs -187.86% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -100.00% vs -27.45% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About OGEN
What is OGEN's market cap?
Oragenics has a market cap of $893,370.
How many shares of OGEN are outstanding?
Oragenics has 4.51M shares outstanding. The count is up 189.06% from a year earlier.
Does OGEN pay a dividend?
No. Oragenics does not pay a dividend.
How much debt does OGEN have?
Oragenics has $396.59K of total debt and $2.23M of cash and equivalents, a net cash position of $1.83M.
OGEN pages: Overview, Charting, Earnings, Financials, Statistics, Competitors